{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:14:07Z","timestamp":1789398847035,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA251599"],"award-info":[{"award-number":["R01 CA251599"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.celrep.2024.115150","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T01:45:58Z","timestamp":1736041558000},"page":"115150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth"],"prefix":"10.1016","volume":"44","author":[{"given":"Joanna","family":"Bandola-Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinaga","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.115150_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.186.1.65","article-title":"Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T\u00a0cell help","volume":"186","author":"Bennett","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2004.03.004","article-title":"Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses","volume":"16","author":"Rocha","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ni1129","article-title":"Cognate CD4(+) T\u00a0cell licensing of dendritic cells in CD8(+) T\u00a0cell immunity","volume":"5","author":"Smith","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4049\/jimmunol.181.1.155","article-title":"Defective MHC class II presentation by dendritic cells limits CD4 T\u00a0cell help for antitumor CD8 T\u00a0cell responses","volume":"181","author":"Gerner","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00262-008-0487-4","article-title":"Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells","volume":"57","author":"Stoitzner","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.115150_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2018.03.025","article-title":"Dysfunction of antigen processing and presentation by dendritic cells in cancer","volume":"113","author":"Bandola-Simon","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic Cells and Cancer Immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115150_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2024.115150_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115150_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1074-7613(00)80249-6","article-title":"Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading","volume":"4","author":"Riese","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115150_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/345615a0","article-title":"Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding","volume":"345","author":"Roche","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115150_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/360474a0","article-title":"HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides","volume":"360","author":"Riberdy","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115150_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1084\/jem.180.3.1107","article-title":"The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy","volume":"180","author":"Romagnoli","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90061-6","article-title":"HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading","volume":"82","author":"Denzin","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1074-7613(95)90089-6","article-title":"DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide","volume":"3","author":"Sherman","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115150_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-5699(97)01006-2","article-title":"How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest?","volume":"18","author":"Kropshofer","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.celrep.2024.115150_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.181.2.677","article-title":"Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II","volume":"181","author":"Sette","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.178.1.27","article-title":"Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles","volume":"178","author":"Chicz","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)81029-6","article-title":"Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway","volume":"84","author":"Miyazaki","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81030-2","article-title":"H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T\u00a0cell repertoire selection","volume":"84","author":"Martin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib24","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1172\/JCI498","article-title":"beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma","volume":"101","author":"Hicklin","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.115150_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00251-008-0303-5","article-title":"Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy","volume":"60","author":"Carretero","year":"2008","journal-title":"Immunogenetics"},{"key":"10.1016\/j.celrep.2024.115150_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4","article-title":"TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis","volume":"95","author":"Kamarashev","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2024.115150_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2103","article-title":"Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in\u00a0vivo","volume":"7","author":"Villadangos","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.immuni.2020.04.005","article-title":"Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection","volume":"52","author":"Bosteels","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115150_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4132","article-title":"pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T\u00a0cells","volume":"8","author":"Rodrigues","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81458-0","article-title":"Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells","volume":"93","author":"Pierre","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib32","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1084\/jem.20180300","article-title":"Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity","volume":"215","author":"Ito","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/jgm.713","article-title":"Genetic approaches for the induction of a CD4+ T\u00a0cell response in cancer immunotherapy","volume":"7","author":"Bonehill","year":"2005","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.celrep.2024.115150_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/intimm\/12.6.757","article-title":"The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses","volume":"12","author":"Chaturvedi","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ni1108","article-title":"Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization","volume":"5","author":"Rohn","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4049\/jimmunol.1002747","article-title":"Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T\u00a0cell responses","volume":"187","author":"Pezeshki","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20020991","article-title":"Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node","volume":"196","author":"Scheinecker","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115150_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T\u00a0cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115150_bib39","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T\u00a0cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib40","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.4049\/jimmunol.180.5.3122","article-title":"Tumor-specific CD4+ T\u00a0cells render the tumor environment permissive for infiltration by low-avidity CD8+ T\u00a0cells","volume":"180","author":"Wong","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4(+) T Cell Immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145885","article-title":"Type 2 dendritic cells mediate control of cytotoxic T\u00a0cell resistant tumors","volume":"6","author":"Iwanowycz","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2024.115150_bib43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1158\/2326-6066.CIR-21-0946","article-title":"Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer","volume":"11","author":"James","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2024.115150_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/tan.14007","article-title":"Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation","volume":"96","author":"Alvaro-Benito","year":"2020","journal-title":"HLA"},{"key":"10.1016\/j.celrep.2024.115150_bib45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/358764a0","article-title":"Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size","volume":"358","author":"Chicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115150_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2005.09.010","article-title":"IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells","volume":"23","author":"Kitamura","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115150_bib47","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.celrep.2015.11.053","article-title":"Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling","volume":"13","author":"Tang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115150_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.celrep.2024.115150_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2024.115150_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-13-43","article-title":"Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization","volume":"13","author":"Yang","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2024.115150_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092021","article-title":"Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery","volume":"9","author":"Fuchs","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2024.115150_bib52","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/0008-5472.CAN-04-1350","article-title":"Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome","volume":"64","author":"Chamuleau","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2024.115150_bib53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.exphem.2008.10.001","article-title":"Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)","volume":"37","author":"Cycon","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.celrep.2024.115150_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/eji.200838674","article-title":"Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter","volume":"39","author":"Choi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.immunol.14.1.301","article-title":"Regulation of MHC class II genes: lessons from a disease","volume":"14","author":"Mach","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib56","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The Basis of Oncoimmunology","volume":"164","author":"Palucka","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115150_bib57","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.163.3.1205","article-title":"Peptide dose, affinity, and time of differentiation can contribute to the Th1\/Th2 cytokine balance","volume":"163","author":"Rogers","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/2326-6066.CIR-14-0232","article-title":"TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy","volume":"3","author":"Shiao","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2024.115150_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102329","article-title":"Tumor immune evasion through loss of MHC class-I antigen presentation","volume":"83","author":"Sari","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115150_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-5699(00)01692-3","article-title":"Antigen-processing machinery breakdown and tumor growth","volume":"21","author":"Seliger","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.celrep.2024.115150_bib62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00262-003-0489-1","article-title":"Down-regulation of HLA class II and costimulatory CD86\/B7-2 on circulating monocytes from melanoma patients","volume":"53","author":"Ugurel","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.115150_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2567.2001.01213.x","article-title":"Tumours can act as adjuvants for humoral immunity","volume":"102","author":"Brown","year":"2001","journal-title":"Immunology"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724015018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724015018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:36:21Z","timestamp":1781555781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724015018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211124724015018"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115150","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115150"}}